Device Trial Radar · NCT05202808
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study
Last checked: Nov 19, 2026Latest source record: Apr 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Actual
Start
Dec 3, 2021
Primary completion
Sep 11, 2024
Study completion Dec 16, 2024
Sponsor
- Lead sponsor
- RxSight, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 24, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to conduct a post-approval study which compares the LAL to a monofocal control IOL for safety outcomes.
Conditions
- Aphakia
- Cataract
Interventions
Light Adjustable lens (LAL) and Light Delivery Device (LDD)Device
Experimental treatment group will receive Light adjustable lens with Light delivery Device treatments
Control IOLDevice
Control treatment group will receive a Control IOL
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Manifest Refraction Spherical Equivalent (MRSE) Compared Between the Two Study Groups, LAL and ControlTime frame: Postop Month 6
- Absolute Manifest Cylinder (MRCYL) Compared Between the Two Study Groups, LAL and ControlTime frame: Postop Month 6
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Vold Vision
Fayetteville, Arkansas
Reeve Woods Eye Center
Chico, California
The Eye Institute of West Florida
Largo, Florida
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.